SE7510505L - PROCEDURE FOR THE PREPARATION OF AN ANTITUMOR PRODUCT - Google Patents
PROCEDURE FOR THE PREPARATION OF AN ANTITUMOR PRODUCTInfo
- Publication number
- SE7510505L SE7510505L SE7510505A SE7510505A SE7510505L SE 7510505 L SE7510505 L SE 7510505L SE 7510505 A SE7510505 A SE 7510505A SE 7510505 A SE7510505 A SE 7510505A SE 7510505 L SE7510505 L SE 7510505L
- Authority
- SE
- Sweden
- Prior art keywords
- procedure
- preparation
- antitumor product
- antitumor
- product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB41037/74A GB1509707A (en) | 1974-09-20 | 1974-09-20 | Immunological compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7510505L true SE7510505L (en) | 1976-03-22 |
Family
ID=10417824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7510505A SE7510505L (en) | 1974-09-20 | 1975-09-19 | PROCEDURE FOR THE PREPARATION OF AN ANTITUMOR PRODUCT |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS5161640A (en) |
| DE (1) | DE2541931A1 (en) |
| DK (1) | DK141773B (en) |
| FR (1) | FR2285145A1 (en) |
| GB (1) | GB1509707A (en) |
| NL (1) | NL7511089A (en) |
| SE (1) | SE7510505L (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4067971A (en) * | 1976-05-13 | 1978-01-10 | The Procter & Gamble Company | Therapeutic composition |
| JPS54132503A (en) * | 1978-04-07 | 1979-10-15 | Kayaku Antibiotic Research Co | Immune globulin combined neocarcinostatin |
| JPS5665829A (en) * | 1979-11-02 | 1981-06-03 | Kureha Chem Ind Co Ltd | Antitumor agent |
| JPS5592325A (en) * | 1978-12-29 | 1980-07-12 | Kureha Chem Ind Co Ltd | Antitumor agent and its preparation |
| JPS5665828A (en) * | 1979-11-02 | 1981-06-03 | Kureha Chem Ind Co Ltd | Antitumor agent |
| US4315851A (en) | 1978-12-29 | 1982-02-16 | Kureha Kagaku Kogyo Kabushiki Kaisha | Pharmaceutical composition having antitumor activity |
| EP0037388B1 (en) * | 1980-03-31 | 1984-12-12 | Institut International De Pathologie Cellulaire Et Moleculaire | Pharmaceutical forms, their preparation and compositions containing the same |
| JPS58118520A (en) * | 1982-01-09 | 1983-07-14 | Hidematsu Hirai | Antitumor proteinic complex and preparation thereof |
| JPS59186924A (en) * | 1983-04-08 | 1984-10-23 | Kureha Chem Ind Co Ltd | Antitumor agent bonded with human immunoglobulin |
| GB2148299B (en) * | 1983-09-01 | 1988-01-06 | Hybritech Inc | Antibody compositions of therapeutic agents having an extended serum half-life |
| DE3513572A1 (en) * | 1985-04-16 | 1986-10-16 | Karl Prof. Dr.med. 7302 Ostfildern Theurer | Preparation of products for specifically influencing the humoral and cellular immune response |
| JPS62228025A (en) * | 1985-12-27 | 1987-10-06 | Teijin Ltd | Production of antibody complex |
| WO1988007553A1 (en) * | 1987-03-26 | 1988-10-06 | Teijin Limited | Process for preparing antibody complex |
| US5773435A (en) * | 1987-08-04 | 1998-06-30 | Bristol-Myers Squibb Company | Prodrugs for β-lactamase and uses thereof |
| AU649275B2 (en) * | 1990-11-06 | 1994-05-19 | Bristol-Myers Squibb Company | Prodrugs for beta-lactamase and uses thereof |
| DE4122210C2 (en) * | 1991-07-04 | 1999-04-01 | Deutsches Krebsforsch | Tumor-active compound-serum albumin conjugates, process for their preparation and their use |
-
1974
- 1974-09-20 GB GB41037/74A patent/GB1509707A/en not_active Expired
-
1975
- 1975-09-19 JP JP50113541A patent/JPS5161640A/en active Pending
- 1975-09-19 DE DE19752541931 patent/DE2541931A1/en not_active Withdrawn
- 1975-09-19 NL NL7511089A patent/NL7511089A/en not_active Application Discontinuation
- 1975-09-19 DK DK422475AA patent/DK141773B/en unknown
- 1975-09-19 SE SE7510505A patent/SE7510505L/en unknown
- 1975-09-19 FR FR7528837A patent/FR2285145A1/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DK141773B (en) | 1980-06-16 |
| DK141773C (en) | 1980-11-03 |
| NL7511089A (en) | 1976-03-23 |
| DE2541931A1 (en) | 1976-04-01 |
| FR2285145B1 (en) | 1980-05-30 |
| JPS5161640A (en) | 1976-05-28 |
| FR2285145A1 (en) | 1976-04-16 |
| DK422475A (en) | 1976-03-21 |
| GB1509707A (en) | 1978-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE437767B (en) | PROCEDURE FOR THE PREPARATION OF AN ANTI-TUMORARY MEDICINAL PRODUCT | |
| SE7902076L (en) | PROCEDURE FOR MANUFACTURE OF IHALIG MOLDING PRODUCTS | |
| SE419605B (en) | PROCEDURE FOR THE PREPARATION OF THE REPRESSED FORM | |
| SE7513085L (en) | PROCEDURE FOR THE PREPARATION OF ETRAR | |
| SE7510505L (en) | PROCEDURE FOR THE PREPARATION OF AN ANTITUMOR PRODUCT | |
| SE412401B (en) | PROCEDURE FOR THE PREPARATION OF POLYVINYLPYRROLIDEN IOD | |
| SE410728B (en) | PROCEDURE FOR THE PREPARATION OF AN ORGANIC COMPLEX | |
| SE7512005L (en) | PROCEDURE FOR THE PREPARATION OF ANTITUMOR Glycosides | |
| SE7506160L (en) | PROCEDURE FOR THE PREPARATION OF N-CYCLOALKYLMETYLDEKAHYDROISOKINOLINE | |
| SE421209B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF TIENOBENZODIAZEPINES | |
| SE409452B (en) | PROCEDURE FOR THE PREPARATION OF STILBENDER DERIVATIVES | |
| SE7506237L (en) | PROCEDURE FOR THE PREPARATION OF DEKAHYDROISOKINOLINE DERIVATIVES | |
| NO143625C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF 2-METOXY-BENZAMIDES | |
| SE411453B (en) | PROCEDURE FOR THE PREPARATION OF 3-FLUORCEPHALOSPORINS | |
| SE403477B (en) | PROCEDURE FOR THE PREPARATION OF SUBSTITUTED INDOLENINS | |
| SE430895B (en) | PROCEDURE FOR CONTINUOUS PREPARATION OF CELLULOSAGLYCOLATE | |
| SE7513739L (en) | PROCEDURE FOR THE PREPARATION OF 2-SCYL-4-OXO-PYRAZINO-ISOCONOLINE DERIVATIVES | |
| SE7511801L (en) | PROCEDURE FOR THE PREPARATION OF IMPAMPOLYMERIZE | |
| SE388854B (en) | PROCEDURE FOR THE PREPARATION OF PHENYLPYRIDYLAMINE DERIVATIVES | |
| SE7506196L (en) | PROCEDURE FOR THE PREPARATION OF AMIDINE-HYDRAZONE DERIVATIVES | |
| RO66137A (en) | PROCESS FOR THE PREPARATION OF CARNITIVE CLORHIDRATE | |
| SE401508B (en) | PROCEDURE FOR BIS PREPARATION (2-PYRIDYL-1-OXIDE) -DISULFID | |
| SE423815B (en) | PROCEDURE FOR THE PREPARATION OF AMINOMETYLARYLMETHYL PENICILLINES | |
| SE420097B (en) | PROCEDURE FOR THE PREPARATION OF HYDROXIAL CHYLXANTINES | |
| SE422679B (en) | PROCEDURE FOR THE PREPARATION OF ETHYNYLBENZEN COMPOUNDS |